Your browser doesn't support javascript.
loading
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy.
Perl, Alexander E; Larson, Richard A; Podoltsev, Nikolai A; Strickland, Stephen; Wang, Eunice S; Atallah, Ehab; Schiller, Gary J; Martinelli, Giovanni; Neubauer, Andreas; Sierra, Jorge; Montesinos, Pau; Recher, Christian; Yoon, Sung-Soo; Maeda, Yoshinobu; Hosono, Naoko; Onozawa, Masahiro; Kato, Takayasu; Kim, Hee-Je; Hasabou, Nahla; Nuthethi, Rishita; Tiu, Ramon; Levis, Mark J.
Afiliación
  • Perl AE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: alexander.perl@pennmedicine.upenn.edu.
  • Larson RA; Division of the Biological Sciences, University of Chicago, Chicago, Illinois.
  • Podoltsev NA; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Strickland S; Department of Internal Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Wang ES; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Atallah E; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Schiller GJ; Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Martinelli G; IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST S.r.l, Meldola, Italy.
  • Neubauer A; Universitätsklinikum Giessen und Marburg GmbH, Marburg, Germany.
  • Sierra J; Hospital de la Santa Creu i Sant Pau and Josep Carreras Leukemia Research Institute, Barcelona, Spain.
  • Montesinos P; Department of Hematology, University Hospital La Fe, Valencia, Spain.
  • Recher C; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse 3 Paul Sabatier, Toulouse, France.
  • Yoon SS; Department of Hemato Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Maeda Y; Department of Hematology and Oncology, Okayama University Hospital, Okoyama, Japan.
  • Hosono N; Department of Internal Medicine, University of Fukui, Fukui, Japan.
  • Onozawa M; Department of Hematology, Hokkaido University, Sapporo, Japan.
  • Kato T; Department of Hematology, University of Tsukuba, Tsukuba, Japan.
  • Kim HJ; Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Hasabou N; Astellas Pharma US, Inc., Northbrook, Illinois.
  • Nuthethi R; Astellas Pharma US, Inc., Northbrook, Illinois.
  • Tiu R; Astellas Pharma US, Inc., Northbrook, Illinois.
  • Levis MJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
Transplant Cell Ther ; 29(4): 265.e1-265.e10, 2023 04.
Article en En | MEDLINE | ID: mdl-36526260
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Tirosina Quinasa 3 Similar a fms Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Tirosina Quinasa 3 Similar a fms Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article